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ur recent studies have shown that extracellular-
regulated protein kinase (ERK) promotes cell death
in cerebellar granule neurons (CGN) cultured in low
potassium. Here we report that the “death” phenotypes
of CGN after potassium withdrawal are heterogeneous,
allowing the distinction between plasma membrane (PM)–,
DNA-, and PM/DNA-damaged populations. These damaged
neurons display nuclear condensation that precedes PM or
DNA damage. Inhibition of ERK activation either by U0126
or by dominant-negative mitogen-activated protein kinase/
ERK kinase (MEK) overexpression results in a dramatic
O
 
reduction of PM damaged neurons and nuclear condensa-
tion. In contrast, overexpression of constitutively active
MEK potentiates PM damage and nuclear condensation.
ERK-promoted cellular damage is independent of caspase-3.
Persistent active ERK translocates to the nucleus, whereas
caspase-3 remains in the cytoplasm. Antioxidants that
reduced ERK activation and PM damage showed no effect
on caspase-3 activation or DNA damage. These data identify
ERK as an important executor of neuronal damage involving
a caspase-3–independent mechanism.
 
Introduction
 
Neural cells die in large numbers during development, and
thereby significantly shape the developing brain (Oppenheim,
1991). In the adult brain, both acute lesions and chronic
neurodegenerative diseases go along with cell death (Nijhawan
et al., 2000). Two types of neuron death are generally
considered to be distinguishable. Acute oxidative stress and
injury can cause necrosis, whereas apoptotic cell death can
be induced by growth factor withdrawal and extracellular
death signals (Martin, 2001). There is growing evidence to
support the notion that neuronal death can result from varying
contributions of coexisting apoptotic and necrotic mechanisms
(Martin, 2001). Thus, a picture is beginning to emerge
suggesting an apoptosis–necrosis cell death continuum.
However, the molecular bases generating this continuum are
still not understood.
Although defined molecular entities that can promote
necrotic cell death are beginning to emerge (Wang, 2000),
molecular players that promote apoptosis have been more
extensively studied. A group of cysteine proteases termed
caspases has been proposed as a major executor of apoptotic
cell death that is accompanied by nuclear condensation and
internucleosomal DNA fragmentation (Hengartner, 2000).
Caspase-3, a pro-enzyme (composed of a short NH
 
2
 
-terminal
pro-domain followed by p17 and p21 subunits), is cleaved
to yield the p17 active fragment upon a cell death stimulus
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(Nicholson et al., 1995). The p17 fragment has been shown
to cleave the inhibitor of the endonuclease caspase-activated
DNase, leading to caspase-activated DNase activation and
resulting in DNA damage (Enari et al., 1998).
Cerebellar granule neurons (CGN) from postnatal rat
provide an excellent system to study neuronal cell death.
CGN survive for weeks in vitro and develop characteristics
of mature CGN when maintained in depolarizing concen-
trations of K
 
 
 
 (25 mM) but undergo cell death when cul-
tured in low K
 
 
 
 (5 mM) conditions (D’Mello et al., 1993).
Although mechanisms underlying CGN death are not yet
fully understood, a requirement of RNA/protein synthesis,
generation of reactive oxygen species (ROS), activation of
caspases, and phosphorylation of c-Jun have been implicated
in this cell death model (Schulz et al., 1996; Watson et al.,
1998).
The MAPKs are serine/threonine protein kinases, which
play pivotal roles in a variety of cell functions in many cell
types (Davis, 1993). Three major mammalian MAPK sub-
families have been described: the extracellular-regulated pro-
tein kinases (ERKs), the c-Jun NH
 
2
 
-terminal kinases (JNK),
and the p38 kinases. Each MAPK is activated by a specific
phosphorylation cascade. The best characterized ERK path-
way involves the activation of Ras at the plasma membrane
(PM) and the sequential activation of a series of protein ki-
nases. Initially, Ras interacts with and activates Raf-1, which
in turn activates MAPK/ERK kinase (MEK)-1 and -2 by
serine phosphorylation. MEK1/2 then catalyze the phos-
phorylation of ERK-1 and -2 on tyrosine and threonine resi-
dues, and these activated MAPKs can phosphorylate cyto-
plasmic or nuclear targets.
Although activation of ERK by some conditions of stress,
particularly oxidant injury, or by growth factors is believed
to confer a survival advantage to cells (Xia et al., 1995; Guy-
ton et al., 1996; Wang et al., 1998), a death-promoting role
of ERK has become increasingly clear recently in both in
vitro and in vivo models of neuronal death. H
 
2
 
O
 
2
 
-induced
ERK induction in an oligodendrocyte cell line was impli-
cated in cell death (Bhat and Zhang, 1999). In primary neu-
ronal cells, glutamate- or camptothecin-induced neuronal
injury was shown to require ERK activation (Stanciu et al.,
2000; Lesuisse and Martin, 2002). In addition, inhibition of
ERK activation protects against cell damage resulting from
focal cerebral ischemia (Alessandrini et al., 1999; Namura et
al., 2001; Noshita et al., 2002). These papers highlight a po-
tentially detrimental role of ERK signaling. However, the
molecular mechanisms orchestrated by ERK to promote cel-
lular demise are not yet clear. We have recently shown that
death of CGN in low K
 
 
 
 is accompanied by a sustained acti-
vation of ERK. Inhibition of persistent active ERK (pERK)
with specific inhibitors resulted in a decrease in c-Jun activa-
tion as well as a decrease in cell death (Subramaniam et al.,
2003).
In an attempt to further explore the mechanistic basis of
ERK-promoted neuronal death, we report the following ma-
jor findings: (a) CGN die by exhibiting features of PM,
DNA, and PM/DNA damage; (b) ERK is predominantly
involved in the execution of PM but not DNA damage–
mediated cell death; (c) the cell death–promoting effect of ERK
is independent of caspase-3; (d) pERK translocates to the
nucleus, whereas caspase-3 remains in the cytoplasm of the
dying neurons; and (e) ERK activation is down-regulated by
antioxidants and protein synthesis inhibitor.
 
Results
 
Low potassium triggers PM and DNA damage in CGN
 
CGN are dependent on depolarizing concentrations of po-
tassium (25–30 mM) for their survival and differentiation.
Changing the high concentration of potassium to a low con-
centration (5 mM) induces cell death. We used three estab-
lished markers for monitoring cellular damage, propidium
iodide (PI) to monitor PM damage, enzymatic TUNEL
staining to monitor DNA damage, and DAPI staining to
monitor morphological changes of nuclei (see Materials and
methods).
3 h after switching to low potassium, 
 
 
 
2% of the neurons
were PI or TUNEL positive. 5 
 
 
 
 1% of the neurons were
both TUNEL and PI positive (Fig. 1, A and B). At 6 h, a
slight but significant increase in the percentages of cells that
were exclusively PI or TUNEL positive was noted. By 12 h,
the number of TUNEL-stained neurons (21 
 
 
 
 1%) was
slightly larger than that of the PI-positive (12 
 
 
 
 1%) neu-
rons. However, at 24 h the number of PI-positive neurons
(31 
 
 
 
 2%) exceeded that of TUNEL-stained neurons (20 
 
 
 
1%). At this point, neurons displaying both TUNEL and PI
staining had increased compared with 12 h (13 
 
 
 
 1 vs. 5 
 
 
 
1%). At 48 h, exclusively PI-positive neurons (42 
 
 
 
 2%)
clearly exceeded the percentage of exclusively TUNEL-posi-
tive neurons (17 
 
 
 
 2%). A significant increase in the neu-
ronal population positive for both PI and TUNEL (22 
 
 
 
1%) occurred at 48 h (Fig. 1 B).
All three neuronal subpopulations characterized by PI,
TUNEL, and TUNEL plus PI staining shown in Fig. 1 C
(asterisk, arrow, and arrowhead, respectively) displayed nu-
clear shrinkage (condensation) in a DAPI-stained specimen.
Measurements of nuclear size showed significant differences
between the PI only, TUNEL only, and TUNEL plus PI
groups (Fig. 1 D). The mean nuclear diameter of PI-positive
neurons (20.66 
 
 
 
 0.81 
 
 
 
m
 
2
 
) was significantly larger (P 
 
 
 
0.001) than that of the TUNEL-stained neurons (13.09 
 
 
 
0.42 
 
 
 
m
 
2
 
) or cells stained for both PI and TUNEL (13.81 
 
 
 
0.81 
 
 
 
m
 
2
 
). Undamaged neurons (TUNEL
 
 
 
/PI
 
 
 
) showed
nuclear diameters of 27.65 
 
 
 
 1.20 
 
 
 
m
 
2
 
.
Together, these results suggest that (a) PI staining indicat-
ing PM and DNA damage identified by TUNEL staining
occurs in partly distinct and partly overlapping subsets of
neurons as early as 6 h after potassium deprivation, (b) by
48 h the fraction of neurons with only PM damage is larger
than the other two neuronal subpopulations, and (c) the
PM-damaged neurons have comparatively larger nuclei than
the DNA-damaged neurons.
 
ERK activation is a prerequisite for PM damage
 
Active ERK1/2 contributes to death of CGN induced by
low potassium because inhibition of ERK1/2 activation pre-
vents CGN death (Subramaniam et al., 2003). The effect
of ERK1/2 inhibition on the aforementioned neuronal
subpopulation was analyzed using the MEK1/2 inhibitor
U0126 (20 
 
 
 
M). U0126 was added to low potassium CGN 
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cultures for 6, 12, 24, and 48 h, and cultures were exposed
to PI and stained with TUNEL and DAPI. U0126 pre-
vented the increase in PI-stained neurons at all the time
points analyzed (Fig. 2 A and Table I), suggesting an active
role of ERK in the execution of PM damage. U0126 also
significantly decreased numbers of TUNEL-positive neu-
rons at 6, 12, and 24 h. However, at 48 h numbers of
TUNEL-positive neurons were no longer significantly dif-
ferent from those in inhibitor-untreated cultures (Table I),
suggesting that ERK inhibition clearly decreased cell death
mediated by PM damage but failed to provide robust and
persistent protection of cells dying by DNA damage. Num-
bers of neurons exhibiting signs of both DNA and PM dam-
age were also significantly decreased by U0126.
The nuclear condensation data (Table I) indicate that, al-
though the U0126 had an early effect (6 and 12 h) on de-
creasing the number of neurons with condensed nuclei
(CN), which are PI-negative, U0126 had a robust effect on
decreasing the CN of PI-positive cells for all time points an-
alyzed. This further characterizes ERK as an inducer of nu-
clear condensation that is predominantly associated with
PM damage. Fig. 2 C represents the photomicrograph of the
DAPI-stained cells in U0126- and DMSO-treated culture,
showing the nuclear condensation (arrows). U0126 clearly
attenuated ERK1/2 activation at all time points analyzed
(Fig. 2 B). A total loss of 
 
 
 
10% of cells both in untreated
Figure 1. Low potassium triggers PM and DNA damage in CGN. 
After potassium change (low K
 ), the CGN were triple stained (see 
Materials and methods). (A) Photomicrographs of PI- (PM damaged), 
TUNEL- (DNA damaged), and TUNEL   PI (DNA and PM damaged)–
stained neurons and their corresponding DAPI stain. (B) Quantification 
of PI  (PM damaged only), TUNEL  (DNA damaged only), and 
TUNEL / PI  (both DNA and PM damaged) neurons are given as a 
percent of the total number of DAPI-stained neurons. (C) Nuclear 
morphologies of damaged neurons; asterisk, only PM damaged; 
arrow, only DNA damaged; arrowhead, both DNA and PM damaged. 
(D) Nuclear size of the damaged neurons at 24 h after low K
  change 
as measured by DAPI-stained nuclei. PI , only PM damaged; 
TUNEL , only DNA damaged; TUNEL /PI , both DNA and PM 
damaged; TUNEL /PI , neither DNA nor PM damaged. Error bars 
represent mean   SEM from at least three experiments. ***P   0.001, 
**P   0.01, and *P   0.05 as compared with the previous time point 
(e.g., *P   0.05 at 48 h is compared with 24 h).
Figure 2. Sustained ERK activation is required for cellular damage. 
(A) Photomicrographs of cells treated with 20  M U0126 and vehicle 
(DMSO, 0.1%) for 12, 24, and 48 h after potassium change. (B) 
Western blot analysis showing sustained ERK activation and its 
attenuation by U1026. (C) DAPI-stained neurons. CN (arrows) in 
the presence of U0126 or DMSO at 48 h. (D) Percentage of total 
DAPI cells in control and in U0126-treated culture. 
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and U0126-treated cultures was observed at 48 h (Fig. 2 D),
suggesting that the U0126 treatment, per se, did not result
in an apparent loss of cells from the culture plate.
In addition, data in Table II demonstrate that at 6 h in
low potassium 
 
 
 
17% of neurons were neither TUNEL pos-
itive nor PI positive but exhibited nuclear condensation
(CN/PI
 
 
 
/TUNEL
 
 
 
), supporting the notion that nuclear
condensation precedes DNA or PM damage. However, at
later time points the total percentage of CN was smaller or
equaled the total percentage of damaged cells. This finding
may be due to a fast and irreversible commitment of neurons
to die around 
 
 
 
12 h after the potassium switch (Miller and
Johnson, 1996). The role of JNK and p38 (the other two
members of MAPK pathway) in PM damage was analyzed.
The JNK inhibitor, JNKI1, had a small but significant effect
on decreasing PM damage, but p38 inhibitor SB203580 had
no apparent effect on PM damage (Fig. S1, available at http:
//www.jcb.org/cgi/content/full/jcb.200403028/DC1).
 
The effect of overexpression of DN MEK and CA MEK 
in CGN
 
CGN were infected with recombinant adenovirus expressing
dominant-negative (DN) MEK, constitutively active (CA)
MEK, and GFP. The proportion of CGN exhibiting both
PM damage and CN in Ad-DN MEK (350 multiplicity of
infection [MOI])–infected cultures was significantly (
 
  
 
P 
 
 
 
0.01) lower than the proportion of such neurons in Ad-
GFP–infected cultures (Fig. 3, A and B). Although 
 
 
 
65%
of the total Ad-GFP–infected neurons exhibited signs of
cellular damage, only 
 
 
 
17% of the total Ad-DN MEK–
infected neurons showed cellular damage. DN MEK overex-
pression markedly inhibited ERK1/2 activation observed in
GFP-infected (control) cultures (Fig. 3 C). Therefore, an in-
hibition of the ERK pathway by pharmacological treatment
or by using Ad-DN MEK can prevent cellular damage, fur-
ther substantiating the role of the MEK–ERK pathway in
neuronal degeneration.
The effect of CA MEK overexpression in CGN was tested
using Ad-CA MEK at 350 MOI. Interestingly, a dramatic
increase in PM-damaged neurons was observed in Ad-CA
MEK–infected as compared with Ad-GFP–infected cultures
(Fig. 3 A; and Fig. 3 B, **P 
 
  
 
0.01). Around 85% of the
Ad-CA MEK–infected neurons were positive for PM dam-
age. 
 
 
 
80% of the Ad-CA MEK–infected neurons displayed
nuclear condensation. CA MEK overexpression-induced
ERK activation is evident at 3 h in low potassium cultures
(Fig. 3 D). At 12 h, Ad-CA MEK overexpression signifi-
cantly increased ERK1/2 phosphorylation compared with
control cultures (Fig. 3 D). At 24 h, ERK1/2 phosphoryla-
tion in Ad-CA MEK–infected CGN culture was reduced
compared with control cultures (unpublished data). This oc-
currence is possibly due to the dramatically accelerated cell
death in Ad-CA MEK–infected neurons that may result in
an overall decrease in phosphorylation of ERK (unpublished
data). These data suggest that Ad-CA MEK overexpression
enhances cellular damage of CGN maintained in low potas-
sium, apparently by increasing the level of ERK activation.
The viral expression for Ad-GFP, Ad-DN MEK, and Ad-
CA MEK (all at 350 MOI) did not result in apparent toxic-
ity (Fig. 3 E).
 
Degeneration promoted by ERK is independent 
of caspase-3
 
We first assayed for an effect of acetyl-Asp-Glu-Val-Asp-
aldehyde (Ac-DEVD-CHO), a selective inhibitor of caspase-3.
Ac-DEVD-CHO (100 
 
 
 
M) efficiently prevented DNA
 
Table II. 
 
Nuclear condensation precedes PM or DNA damage
Low K
 
 
 
CN CN/PI
 
 
 
/TUNEL
 
 
 
CN/PI
 
 
 
/TUNEL
 
 
 
CN/PI
 
 
 
/TUNEL
 
 
 
CN/PI
 
 
 
/TUNEL
 
 
 
h % %%%%
 
6 31 
 
 
 
 24  
 
 
 
 16  
 
 
 
 14  
 
 
 
 2 17 
 
 
 
 2
12 37 
 
 
 
 2 12 
 
 
 
 2 19 
 
 
 
 15  
 
 
 
 12  
 
 
 
 1
24 64 
 
 
 
 2 31 
 
 
 
 2 21 
 
 
 
 1 12 
 
 
 
 12  
 
 
 
 1
Percentage of total number of CN, which are damaged only for PM (CN/PI
 
 
 
/TUNEL
 
 
 
), or DNA (CN/PI
 
 
 
/TUNEL
 
 
 
), or both (CN/PI
 
 
 
/TUNEL
 
 
 
). CN/PI
 
 
 
/
TUNEL
 
 
 
 condensed neurons neither PM nor DNA damaged.
Table I. 
 
ERK activation promotes PM damage and nuclear condensation
DMSO U0126
Low K
 
 
 
PI  TUNEL  TUNEL /PI  CN/PI  CN/PI  PI  TUNEL  TUNEL /PI  CN/PI  CN/PI 
h% % %% % % % %% %
64     16    14    18    2 23   32    13    15    17    16    1
a
12 12   1 19   15    1 17   1 20   14    1
a 10   1
a 6   1 11   2
a 10   1
a
24 31   2 21   1 12   1 44   1 21   3 13   1
a 14   17    1
b 18   2
a 15   2
48 41   2 16   2 22   3 63   2 16   1 12   1
a 21   1 14   2
c 23   1
a 14   1
At the time of potassium change (low K
 ), U0126 (20  M) or DMSO (0.1%) was added for 6, 12, 24, and 48 h, and triple staining was performed. Data are
given as a percentage of the total number of PI , TUNEL , and TUNEL /PI  neurons. Percentage of total neurons with condensed nuclei (CN), which are
PI  and PI , are also given.
aP   0.001 compared with DMSO treatment.
bP   0.01 compared with DMSO treatment.
cP   0.05 compared with DMSO treatment.Mechanism of ERK-induced neuronal damage | Subramaniam et al. 361
damage and condensation of nuclei but failed to prevent PI
uptake, suggesting an involvement of a caspase-3–indepen-
dent mechanisms in neuronal PM damage (Fig. 4 A). This
observation is in line with a previous paper (D’Mello et
al., 2000) showing that potassium-deprived CGN cultured
from caspase-3 ( / ) mice die without showing signs of
DNA fragmentation.
Because ERK inhibition efficiently prevented PM damage
and nuclear condensation, but had only a delaying effect on
DNA damage (Table I), we investigated if ERK activation
regulates caspase-3 cleavage (activation), which is known to
orchestrates DNA damage (Enari et al., 1998). Caspase-3 is
activated in parallel to pERK after potassium deprivation
(Fig. 4 B). Both PD98059 (50  M) and U0126 (20  M)
failed to prevent cleavage of the active caspase-3 subunit,
and they did not affect its activity (Fig. 4, C and E), suggest-
ing that inhibition of ERK does not prevent caspase-3 cleav-
age nor caspase-3 activity. Because treatment with U0126
somewhat delayed DNA damage (Table I), it is conceivable
that ERK may act on downstream targets of caspase-3 to
promote DNA fragmentation. MEK/ERK inhibitors pre-
vented ERK activation, implying their activity in these treat-
ments, with U0126 being more potent than PD98059 (Fig.
4 C).
Effect of the pan caspase inhibitor on
neuronal degeneration
In addition to preventing PM damage, inhibition of ERK
also prevented nuclear condensation independent of cas-
pase-3.  14 mammalian caspases have been identified so far
(Chinnaiyan and Dixit, 1996). Therefore, it is conceivable
that ERK may induce cell demise through any of these cas-
Figure 3. Infection of CGN with recombinant adenovirus. (A) Fluorescence microscopy of CGN 
infected with Ad-GFP, Ad-DN MEK, and Ad-CA MEK and costained for PI and DAPI. An antibody 
against HA-tagged epitope was used to detect DN and CA MEK expression. (B) Quantification of 
the percentage of total PI-positive cells and cells with condensed nuclei (CN) in control (uninfected) 
and in Ad-GFP–, Ad-DN MEK–, and Ad-CA MEK–infected populations. ***/   P   0.001, 
**/  P   0.01, and */ P   0.05 compared with Ad-GFP infected neurons. (C and D) Immunoblot 
analysis of pERK in control, Ad-GFP–, Ad-DN MEK–, and Ad-CA MEK–infected neurons. **P   0.01 
is Ad-DN MEK versus Ad-GFP at 24 h; *P   0.05 is Ad-CA MEK versus control (uninfected) at 
12 h. (E) Quantification of CN as estimated by DAPI in adenoviral-infected neurons.362 The Journal of Cell Biology | Volume 165, Number 3, 2004
pases. To test this possibility, we made use of the pan cas-
pase inhibitor benzyloxycarbonyl-Val-Ala-Asp-fluorometh-
ylketone (Z-VAD-FMK). Treatment with Z-VAD-FMK
(100  M) significantly reduced both PM damage and nu-
clear condensation compared with the specific caspase-3 in-
hibitor. However, neither of the two (pan caspase or cas-
pase-3 specific inhibitor) was as effective as the ERK inhibitor
U0126 in preventing PM damage and nuclear condensation
(Fig. 4 A). Together, these data suggest that both ERK and
caspases other than caspase-3 are involved in promoting
neuronal degeneration. In addition, Z-VAD-FMK attenu-
ated both caspase-3 cleavage and its activity, but failed to
prevent ERK activation, suggesting that ERK is either up-
stream or independent of caspases in this paradigm (Fig. 4,
D and E).
ERK translocates to the nucleus and caspase-3 remains 
in the cytoplasm
Activation of ERK1/2 results in its translocation from the
cytoplasm to the nucleus, where it phosphorylates and regu-
lates the activity of several transcription factors (Reiser et al.,
1999). To test if pERK translocates to the nucleus in CGN,
we performed PI/DAPI or TUNEL/DAPI staining followed
by the immunocytochemical visualization of pERK. After
the 6 h of potassium switch, the majority ( 58%) of the
neurons displayed pERK immunoreactivity in the cytoplasm
(Fig. 5 A, arrowheads; and Fig. 5 B) compared with its nu-
clear localization ( 8%). In contrast, 42% of the neurons at
24 h displayed high pERK immunoreactivity in the nucleus
(Fig. 5 A, arrows and asterisks; and Fig. 5 B), and  28% of
the neurons showed pERK staining still in the cytoplasm
(Fig. 5 B). These data suggest that ERK is activated in the
cytoplasm as early as 6 h and undergoes nuclear transloca-
tion to regulate genes or proteins required for promoting
neuronal degeneration.
The quantification of pERK immunoreactivity in PM- and
DNA-damaged neurons is shown in Fig. 5 C. At 24 h, a ma-
jority of PM-damaged neurons ( 45%) are positive for nu-
clear translocated pERK (nuclear pERK/PI ) compared with
DNA-damaged neurons ( 12%, nuclear pERK/TUNEL ).
Figure 4. The role of caspase in CGN 
degeneration. (A) Caspase-3 and pan 
caspase inhibitors selectively prevent 
neuronal degeneration. After potassium 
change (low K
 ), neurons were incubated 
with 0.5% DMSO, 100  M caspase-3 
inhibitor Ac-VAD-CHO, 100  M pan 
caspase inhibitor Z-VAD-FMK, or 20  M 
U0126 for 24 h, and triple staining was 
performed. Data represent the total 
number of neurons positive for PI 
(PM damaged), TUNEL (DNA damaged), 
TUNEL   PI (both DNA and PM 
damaged), and neurons with CN. 
***P   0.001, **P   0.01, and *P   0.05 
was compared with DMSO treatment. 
(B) Caspase-3 is activated (active cas-3) 
in parallel to ERK activation. Cells were 
harvested at the indicated time points 
and processed for Western blot analysis 
to detect total ERK (ERK), pERK, and 
caspase-3 (pro and active fragment). 
(C) MEK/ERK inhibitors do not prevent 
caspase-3 cleavage. Cells were harvested 
after 50  M PD98059 or 20  M U0126 
treatment and probed for pERK, caspase-3, 
and tubulin. (D) Pan caspase inhibitor 
blocks caspase-3 activation but shows 
no effect on ERK activation. Cells were 
harvested after 100  M Z-VAD-FMK or 
0.2% DMSO treatment, and Western 
blot analysis was performed for pERK, 
caspase-3, and tubulin. (E) Measurement 
of caspase-3 activity. 50  M PD98059, 
20  M U0126, 100  M Z-VAD-FMK, or 
0.2% DMSO was added for the indicated 
time points, and cell extracts were assayed 
for caspase-3 activation. The control 
assay was performed without the cell 
extract (blank).Mechanism of ERK-induced neuronal damage | Subramaniam et al. 363
This finding suggests that the same percentage of cells that
shows pERK nuclear immunoreactivity eventually undergoes
PM damage (Fig. 5, compare B and C). In addition, a larger
number of nuclear pERK/PI  neurons compared with nu-
clear pERK/TUNEL  neurons further corroborate the find-
ing that ERK activation predominantly directs PM damage
(Fig. 5 C and Table I). It should be noted that the large num-
ber of PI-positive neurons are nuclear pERK positive ( 45%)
compared with only PI–positive neurons (Table I,  31%).
These 45% of the PI-positive neurons with nuclear pERK are
the combined total of all PI positive neurons (Table I, only PI
[31%] plus TUNEL   PI [13%]).
At 6 h in low potassium,  20% of the neurons with cyto-
plasmic pERK immunoreactivity (Fig. 5 A, arrowheads) were
neither PI nor TUNEL positive (Fig. 5 D) but had already
undergone changes in their nuclear morphology associated
with prominent condensation (evident in DAPI staining).
These observations indicate that an intense ERK activation
occurs in the cytoplasm, and that changes in nuclear mor-
phology occur before PM or DNA damage (Table II, 6 h).
Next, we analyzed the cellular localization of caspase-3
and its distribution in different subsets of damaged neurons.
Activated caspase-3 remains restricted to the cytoplasm of
neurons (Fig. 6 A; and Fig. 6 D, arrows). A larger number
of DNA-damaged neurons appeared positive for caspase-3
(cyto-cas-3/TUNEL ) compared with PM-damaged (cyto-
cas-3/PI ) neurons (Fig. 6 B), indicating that caspase-3 ac-
tivation is predominantly associated with DNA damage in
CGN. Fig. 6 C shows that PI-positive neurons (PM damage,
arrow) are negative for caspase-3. In contrast, TUNEL-posi-
tive neurons (DNA damage; Fig. 6 C, asterisks) are positive
for caspase-3, further corroborating the finding that PM
damage in CGN is not associated with caspase-3 activation.
Colocalization of pERK and caspase-3 revealed that at 24 h
after potassium withdrawal  15% of the neurons were dou-
ble-stained for pERK and caspase-3 (Fig. 6, D and E). Note
that caspase-3 remained in the cytoplasm (Fig. 6 D, arrow)
and pERK translocated to the nucleus (Fig. 6 D, arrowhead)
at 24 h in low K
 .
Effect of antioxidants and protein synthesis inhibitor 
in neuronal damage
We tested the effect of antioxidants on cellular damage. Both
the antioxidant N-acetyl cystein (N-AC; 5 mM) and super-
oxide dismutase (SOD; 50 U/ml) significantly reduced num-
bers of neurons with CN and PM damage but failed to pre-
vent DNA damage (Fig. 7 A). Previous works have shown
that ROS can activate ERK. Therefore, we investigated the
effect of N-AC and SOD on ERK as well as caspase-3 activa-
tion. Both N-AC and SOD reduced ERK activation for the
time points analyzed (6 and 12 h), but failed to prevent cas-
pase-3 cleavage as well as its activity (Fig. 7 B).
Next, the effect of the protein synthesis inhibitor cyclo-
hexamide (CHX) on nuclear condensation, PM and DNA
Figure 5. Cellular distribution of pERK 
in subsets of damaged neurons. (A) 
Fluorescence microscopy of the pERK in 
damaged neurons. After potassium change 
(low K
 ), CGN were processed for pERK 
immunocytochemistry combined with 
either TUNEL or PI staining and nuclear 
staining (DAPI) for 3, 6, and 24 h. 
arrowheads, pERK in the cytoplasm and 
corresponding TUNEL or PI-negative 
neurons; arrows, pERK in the nucleus 
and corresponding PI- stained neurons; 
asterisks, pERK in the nucleus and corre-
sponding TUNEL-positive neurons. (B) 
Quantification of the cellular distribution 
of pERK at 6 and 24 h after potassium 
change, in the nucleus (nuclear pERK), 
and in the cytoplasm (cyto pERK). (C) 
Quantification of pERK in damaged 
neurons at 6 and 24 h. (D) Quantification 
of pERK immunoreactivity in CN with 
cellular damage at 6 and 24 h. Error bars 
represent mean   SEM from at least 
three experiments.364 The Journal of Cell Biology | Volume 165, Number 3, 2004
damage was investigated. CHX treatment (10  g/ml) dra-
matically diminished all cellular damage (Fig. 7 A). To fur-
ther unravel signaling mechanisms, by which CHX pre-
vented cellular damage, we determined levels of pERK and
caspase-3 in CGN cultures treated with CHX. CHX treat-
ment abrogated both ERK activation and caspase-3 activity,
indicating the requirement of new proteins for ERK and cas-
pase-3 activation (Fig. 7, B and C).
Next, we tested the possibility that CHX may act directly
by binding to ERK and caspase-3 rather than inhibiting the
synthesis of protein. CHX added at 0 and 12 h and cell ly-
sates were processed to detect pERK and caspase-3 at 13 h
after the potassium change. CHX added at 0 h effectively
abolished caspase-3 and ERK activation but did not do so at
12 h, suggesting that CHX specifically acts by inhibiting
protein synthesis (Fig. 7 D). If CHX can act directly, by
binding to ERK and caspase-3, it should have done so even
when added at 12 h, as U0126, which effectively abrogated
ERK activation when added even at 12 h. U0126 directly
binds to MEK and thereby attenuates ERK activation (Fa-
vata et al., 1998). Note that U0126 failed to inhibit caspase-3
cleavage (Fig. 7 D).
Together, these results indicate that the “death” pheno-
types of CGN after potassium withdrawal are heteroge-
neous, allowing to distinguish between PM-, DNA-, and
membrane/DNA-damaged populations. Most of these dam-
aged neurons display nuclear condensation, which is an early
event that precedes PM or DNA damage. As summarized in
Fig. 8, we have demonstrated by using various inhibitor
strategies that ERK inhibition results in a dramatic reduc-
tion of PM-damaged neurons and nuclear condensation, un-
derscoring the crucial role played by ERK in CGN degener-
ation. Interestingly, this effect of ERK is independent of
caspase-3. In contrast, inhibition of caspase-3 largely pre-
vented DNA damage and moderately reduced nuclear
condensation (Fig. 8, open arrow) without affecting PM
damage. The dotted arrow indicates late PM damage in
DNA-damaged neurons (Fig. 8).
Discussion
Low potassium triggers a unique mode of cell death
The present work shows that degeneration of CGNs in-
duced by switching from high to low potassium occurs
along three distinct routes toward death: (1) cells undergo-
ing only PM damage, (2) cells that exhibit only DNA dam-
age, and (3) cells exhibiting both DNA and PM damage.
Most neurons showing either or both of these cellular phe-
notypes also have CN. CGN death following potassium
deprivation has been considered to be apoptotic (D’Mello
et al., 1993; Miller and Johnson, 1996). Condensation of
nuclei and DNA fragmentation are widely accepted as es-
sential features of cells undergoing apoptosis (Vaux, 1993;
Majno and Joris, 1995). If at all, PM damage has been
conceived as a late event in apoptosis (Vaux, 1993). Neu-
rons with exclusive DNA damage or a combination of
DNA and PM damage (thought to represent a late stage of
apoptosis) fulfill salient criteria of apoptosis. The large
population of CGN showing PM damage only contradicts
the hypothesis that CGN cell death occurs exclusively by
apoptosis. Cell swelling, with an early loss of PM integrity
and major changes of organelles, including nuclear swell-
ing, are considered as essential features of cells undergoing
necrosis (Vaux, 1993). Thus, those CGN exhibiting signs
Figure 6. Cellular distribution of activated caspase-3 in subsets of damaged neurons. After potassium change (low K
 ), CGN were processed 
for immunocytochemical detection of cleaved (activated) caspase-3 combined with either TUNEL or PI staining and nuclear staining (DAPI) 
for 6 and 24 h. (A) Quantification of the cellular distribution of caspase-3 at 6 and 24 h after potassium change in the nucleus (nuclear cas-3) 
and in the cytoplasm (cyto cas-3). (B) Quantification of caspase-3 immunoreactivity in damaged neurons at 6 and 24 h. (C) Fluorescence 
microscopy immunodetection of caspase-3 in damaged neurons at 24 h. PM-damaged (PI) neurons are negative for caspase-3 (arrows), and 
DNA damaged (TUNEL) neurons are positive for caspase-3 (asterisks). (D) Colocalization of pERK and caspase-3 after potassium change 
at 6 and 24 h. Arrows, caspase-3–positive cells; arrowheads, pERK-positive cells; asterisks, CN. (E) Quantification of pERK and caspase-3 
colocalization. Error bars represent mean   SEM from at least three experiments.Mechanism of ERK-induced neuronal damage | Subramaniam et al. 365
of PM damage at relatively early stages after potassium
withdrawal may be conceived to undergo necrosis. How-
ever, these neurons showed significant condensation rather
than swelling of nuclei. Therefore, the absence of DNA
fragmentation and the occurrence of necrotic-like PM
damage with apoptotic-like nuclear condensation suggest
that low potassium induces an unusual type of cell death,
which does not meet the criteria of classical necrosis or
classical apoptosis, respectively.
There is a growing debate regarding the definition of dis-
tinct categories of cell death. For example, a clear-cut dis-
tinction between apoptosis and necrosis is getting increas-
ingly difficult because both modes of cell death share
common features. Over the last years, exceptions have been
found for essentially all of the criteria that define apoptosis
(Maher and Schubert, 2000; Kanduc et al., 2002; Sloviter,
2002). Using an established model of neuronal cell death,
our data reveal that the cell death “phenotypes” are not
only heterogeneous but also display features of yet unde-
fined forms of cell death. At present, it is unclear how to
categorize neurons with only PM damage. The occurrence
of cell death that fulfills neither the criteria of apoptosis
nor necrosis has been documented in various cell types in-
cluding neurons (Pilar and Landmesser, 1976; Clarke,
1990; Cornillon et al., 1994; Dal Canto and Gurney, 1994;
Jurgensmeier et al., 1997). Particularly interesting is the
IGF1R-induced cell death of 293T cells called “paraptosis”
that shares some of the features described in our paper
(Sperandio et al., 2000). Thus, paraptosis includes relative
resistance to caspase inhibitors, absence of TUNEL staining,
chromatin condensation, and cyclohexamide dependence.
However, cytoplasmic vacuolation, an essential characteris-
tic feature of paraptosis, was not observed in our EM anal-
yses of low potassium-induced cell death (unpublished data).
This suggests that paraptosis and CGN neuron death may
be two different entities.
ERK promotes PM damage
Although a role of ERK activation in cell death has been
suggested for other neuronal systems (Alessandrini et al.,
1999; Stanciu et al., 2000), the underlying mechanisms and
intracellular networks linking ERK activation to the specific
cellular damage were previously unknown. We have now
shown for the first time a role of ERK activation in promot-
ing exclusively PM damage independent from caspase-3–
mediated apoptotic cell death. Inhibition of ERK not only
reduced the percentage of the PM-damaged subpopulation
of neurons but also decreased the late PM damage in neu-
rons with DNA damage. This finding suggests that ERK ac-
tivation is indispensable for PM damage. In contrast to the
prominent effect of ERK inhibition on PM damage, its ef-
fect on DNA damage was only transient (at 12 and 24 h). In
Figure 7. Effect of antioxidants and 
protein synthesis inhibitor on neuronal 
degeneration and ERK/caspase-3 activa-
tion. At the time of potassium change 
(low K
 ), 5 mM N-acetyl cysteine (N-AC), 
50 U/ml superoxide dismutase (SOD), or 
10 g/ml cyclohexamide (CHX) was added; 
and triple staining and Western blot 
analysis were performed at the indicated 
time points. (A) The triple staining for 
the aforementioned groups at 24 h. 
***P   0.001, **P   0.01, and *P  0.05 
compared with untreated cultures. (B) 
Western blot probed for total ERK (ERK), 
p-ERK, and caspase-3. (C) 5 mM N-AC, 
50 U/ml SOD, and 10 g/ml CHX were 
added immediately after potassium 
change, and cell extracts were assayed 
for caspase-3 activation; —, untreated; 
blank, without cell extract. Error bars 
represent mean   SEM from at least six 
experiments. (D) CHX does not act by 
binding to ERK and caspase-3. 10 g/ml 
CHX was added at 0 and 12 h after the 
potassium switch. 20  M U0126 was 
added at 12 h. The cell lysates were 
isolated after 13 h and processed for 
caspase-3 and ERK activation. Tubulin 
and total ERK blots reveal total protein 
loading.366 The Journal of Cell Biology | Volume 165, Number 3, 2004
addition, ERK inhibition also provided significant protec-
tion on nuclear condensation, thus expanding its role not
only as an executer of PM damage but also of nuclear con-
densation (Table I). It should be noted that CA-MEK does
not induce apparent cell death in high potassium culture
(Fig. 3 E). We and others (Miller et al., 1997b) have ob-
served that high potassium CGN culture exhibit an elevated
ERK activation, and an abolishment of ERK activation by
MEK inhibitors does not interfere with the high potassium-
mediated CGN survival (unpublished data). This observa-
tion suggests that the high potassium-promoted survival is
independent of ERK activation. Therefore, overexpression
of CA MEK had no apparent effect on CGN survival in
high potassium.
Caspase-3 is not required for PM damage
Further, we analyzed the localization of activated ERK
(pERK) in an attempt to understand the expression pat-
tern of pERK in these damaged neurons. Interestingly, an
intense nuclear localization of pERK immunoreactivity
was observed in both PI-stained and TUNEL-stained neu-
rons, however, with different proportions. A large number
of PM-damaged neurons were pERK positive compared
with DNA-damaged neurons at 24 h. This result further
suggests that ERK activation is predominantly involved in
PM damage. Even though ERK activation could be ob-
served in DNA-damaged neurons, the failure of ERK inhi-
bition (upon U0126 treatment) to afford strong protec-
tion against DNA damage hints to the possibility of an
involvement of an ERK-independent pathway to promote
DNA damage.
One such potential pathway is the caspase-3–dependent
pathway. Several lines of evidence suggest that caspase-3
crucially controls cellular changes related to apoptosis
(Chinnaiyan and Dixit, 1996). In our paradigm blocking
of caspase-3 largely prevented DNA, but not PM, damage.
In addition, our immunofluorescense study of caspase-3
and pERK in subsets of damaged neurons suggests that
DNA and PM damage are controlled by distinct molecular
mechanisms: pERK promotes PM damage, and caspase-3
promotes DNA damage. Furthermore, a pan caspase inhib-
itor, which attenuated caspase-3 activation but failed to
prevent ERK activation, corroborates the notion that cas-
pase-3 and ERK not only command distinct cellular dam-
age but also act independently in the process of neuronal
degeneration.
Interestingly, ERK is activated in the cytoplasm, but
showed a prominent nuclear localization in neurons with
CN. Similarly, active caspase-3 was also seen in the cyto-
plasm of neurons, but only in those with CN (Fig. 6 D).
The fact that ERK promotes cell death independent of cas-
pase-3, together with this differential expression pattern,
suggests that ERK and caspase-3 may use distinct targets to
advance the process of neuronal degeneration. Although
ERK seems to modulate both cytoplasmic and nuclear tar-
gets, caspase-3 may rather focus on cytoplasmic substrates.
A model for the two distinct pathways involving ERK and
caspase-3 activation for the performance of two distinct
types of cell damage is presented in Fig. 8. It is not clear as
yet whether or not ERK acts independently of all known
caspases. The fact that a general caspase inhibitor was more
potent in preventing neuronal degeneration than the specific
caspase-3 inhibitor suggests that ERK may target caspases
other than caspase-3 for promoting degeneration. Neverthe-
less, the more robust protection by inhibiting ERK rather
than caspases (Fig. 4 A) suggests that ERK activation plays a
major role in CGN death after potassium deprivation, possi-
bly independent of all known caspases.
A caspase-independent mechanism of cell death has been
reported in various other models of neuronal cell death. Cell
death induced by methyl mercury in CGN (Castoldi et al.,
2000), by serum deprivation in cortical neurons (Hamabe et
al., 2000), by kainic acid in CGN (Verdaguer et al., 2002),
and by H2O2 in PC12 cells (Jiang et al., 2001) has been re-
ported to be independent of caspases. In addition, it has
been proposed that loss of CGN viability maintained in low
potassium might involve a mechanism independent of cas-
pases (Miller et al., 1997a). As our study demonstrates for
the first time, ERK acts independently of caspase-3 to pro-
mote degeneration in this paradigm, it is tempting to specu-
late that the ERK pathway may be part of a largely caspase-
independent mechanism of neuronal cell death.
Potential targets and regulators of ERK
We have previously shown that one of the potential targets
of ERK activation is c-Jun protein expression and phos-
phorylation (Subramaniam et al., 2003), a prerequisite for
CGN death (Watson et al., 1998). Interestingly, the early
growth response gene-1 (Egr-1) is activated at 6 h (i.e., at
the time when ERK is also activated) and induces c-Jun
activation, which promotes cell death in this paradigm
(Levkovitz and Baraban, 2002). egr-1 contains five serum
response elements and can be regulated by Elk1, a key
component binding to serum response elements (Cibelli
et al., 2002). It has been demonstrated that Elk-1 is a tar-
get of ERK (Davis, 1993). Because Elk-1 controls egr-1,
which in turn controls c-Jun activation (Levkovitz and
Baraban, 2002), we hypothesize that ERK may indirectly
activate c-Jun via the intermediate targets Elk-1 and
Figure 8. Diagram summarizing the role of ERK and caspase-3 in 
the degeneration of CGN. U0126, MEK1/2 inhibitor; Z-VAD-FMK, 
pan caspase inhibitor; Ac-DEVD-CHO, caspase-3 inhibitor; AO, 
antioxidants; CHX, cyclohexamide. For description, see the end of 
the Results section.Mechanism of ERK-induced neuronal damage | Subramaniam et al. 367
Egr-1. In addition, it has been demonstrated that ERK di-
rectly phosphorylates c-Jun (Pulverer et al., 1991), raising
the possibility that ERK is directly involved in the regula-
tion of c-Jun.
We have previously demonstrated that ROS acts up-
stream of ERK in this CGN paradigm (Subramaniam et al.,
2003). The use of two different antioxidants (N-AC and
SOD) prevented ERK activation only in part ( 40%), sug-
gesting that ROS acts upstream of ERK but contributes
partially to ERK activation. Interestingly (Noshita et al.,
2002), it has been demonstrated that overexpression of
SOD1 prevents cell death after transient focal cerebral
ischemia by preventing ERK1/2 activation, suggesting that
ROS acts upstream of ERK.
Growing evidence suggests that ERK activation is promi-
nently involved in neurodegeneration, including animal mod-
els of ischemia (Alessandrini et al., 1999; Noshita et al., 2002).
With regard to human neurodegenerative disorders, phos-
phorylated ERK immunoreactivity has been found in neurons
in Pick’s disease, progressive supranuclear palsy, and cortico-
basal degeneration (Ferrer et al., 2001). In Alzheimer’s disease,
phosphorylated ERK immunoreactivity in a granular appear-
ance has been described in a subpopulation of hippocampal
neurons with neurofibrillar degeneration (Perry et al., 1999).
More recently, granular cytoplasmic aggregates of pERK have
been shown in the substantia nigra of patients with Lewy body
disease (Zhu et al., 2002), suggesting a possible role of ERK
activation in this human neurodegenerative disorder.
In summary, the present work provides evidence not only
for the generation of different morphological phenotypes of
damaged neurons but also for the unique role of ERK in the
execution of PM damage through a mechanism that is inde-
pendent of caspase-3. It remains to be resolved whether or
not this mechanism operates also in other neuronal death
paradigms.
Materials and methods
Cell culture
CGN were isolated and cultured from 8-d-old Wistar rats as described pre-
viously (Subramaniam et al., 2003). Cells were resuspended in high K
 
(Eagle’s basal medium containing 10% FCS, 25 mM KCl, 2 mM glutamine,
and 0.5% [vol/vol] penicillin/streptomycin), switched to low K
  (Eagle’s
basal medium, 5 mM KCl, 2 mM glutamine, and 0.5% penicillin/strepto-
mycin) at day 4, treated with additives for the indicated time points, and
processed for the specific assays described in the following paragraph.
Triple staining for PI uptake, TUNEL, and DAPI
At the indicated time points, 5  g/ml PI, an established marker for PM
damage, was added directly to the culture medium and incubated at 37 C
for 10 min. Cells were washed and fixed with 4% PFA, permeabilized with
0.2% Triton X-100, and processed for TUNEL (Promega). 5  g/ml DAPI
was added to stain cell nuclei. Photomicrographs from 4–6 different fields
in each coverslip were captured under red (PI), green (TUNEL), and blue
(DAPI) channels and merged using adobe photoshop 5.5. Typically,  500
cells were analyzed for the number of only PI-stained (PM damaged) or
only TUNEL-positive (DNA damaged), or both TUNEL- and PI-positive
(DNA and PM damaged) neurons. Total numbers of neurons with CN were
also counted wherever indicated. Cell numbers were presented as a per-
centage of degenerated cells in relation to total cell numbers.
Acquisition of microscope images
Cells were examined with a computer-controlled fluorescence microscope
(model Axioplan 2 imaging; Carl Zeiss MicroImaging, Inc.) equipped with
a high resolution digital camera (model Axiocam; Carl Zeiss MicroImag-
ing, Inc.) under control of Axiovision 3.1 software (Carl Zeiss MicroImag-
ing, Inc.). Depending on the experiments, images were made using 20, 40,
or 63  Neofluar objectives with numerical aperture 0.5, 0.75, and 1.25,
respectively.
Preparation and infection of recombinant adenoviruses
CA-MEK-1, cDNAs (G1C,  N4-S218E/S222D) encoding an HA epitope
tag, was provided by N. Ahn (University of Toronto, Toronto, Ontario,
Canada; Mansour et al., 1996). HA-tagged K97M DN mutant form of MEK,
CA MEK, and GFP were cloned and expressed in adenoviruses as de-
scribed previously (Mazzoni et al., 1999; Shalin et al., 2004). Recombi-
nant adenoviruses expressing GFP were used to determine MOI. Infection
rates 55% to 80% were routinely obtained with 300–500 MOI. 350 MOI
was used for all the experiments. On DIV2.5, CGN were infected with ad-
enoviruses expressing DN MEK, CA MEK, or GFP, and on DIV4, medium
was changed to low potassium. On DIV5, cells were processed for cell
death and Western blot analysis. Cell death was presented as a percentage
of total cells that were PM damaged or exhibited CN. Western blot analy-
sis was performed to detect overexpressed HA-MEK using an antibody
against MEK1/2 (New England Biolabs, Inc.).
Quantification of pERK and caspase-3 localization in 
damaged neurons
After the potassium switch, the cells were processed for the following com-
binations of staining: pERK/PI/DAPI, pERK/TUNEL/DAPI, caspase-3/PI/
DAPI, and caspase-3/TUNEL/DAPI, for the indicated time points. The per-
centages of pERK- or caspase-3–positive cells were determined by count-
ing 500 cells per field. Cell numbers were presented as percentages of
stained cells in each subset (PI positive and TUNEL positive) in relation to
the total cell number.
Nuclear size measurements
The area of DAPI-stained nuclei of normal (neither PI nor TUNEL stained),
only PI-stained, only TUNEL-stained, or both TUNEL and PI-stained neu-
rons were measured using Image tool 3.0 software (UTHSCSA).
Immunocytochemistry
Cells were fixed in 4% PFA, permeabilized with 0.2% Triton X-100, and
blocked with 5% normal horse serum followed by incubation with an mAb
for pERK or a polyclonal antibody for cleaved caspase-3. Cells were incu-
bated with anti–mouse IgG conjugated with CY2. In the case of pERK or
caspase-3/PI costaining, PI was added before fixing the cells. In the case of
pERK or caspase-3/TUNEL costaining, TUNEL staining was performed be-
fore pERK or caspase-3 immunocytochemistry as aforementioned using
streptavidin CY3. In the case of the pERK/caspase-3 visualization, the anti-
body against pERK was incubated overnight followed by incubation with
the antibody for cleaved caspase-3. Cultures were incubated with CY2-
conjugated anti–mouse and CY3-conjugated anti–rabbit antibody, respec-
tively. 5  g/ml DAPI was added in all cases. Immunostaining for overex-
pressed DN MEK and CA MEK was performed using polyclonal antibody
against HA-tagged epitope (Babco).
All other antibodies were obtained from New England Biolabs, Inc. All
CY2/CY3-conjugated fluoroprobes were obtained from Dianova.
Western blot analysis
Western blot analysis was performed exactly as described previously (Sub-
ramaniam et al., 2003).
Assay of caspase-3 enzymatic activity
Caspase-3 activity was assayed as described previously (Verdaguer et al.,
2002). Results were expressed as units of absorbance. Caspase-3 inhibitors
Ac-DEVD.CHO, Z-VAD-FMK, U0126, and PD98059 were obtained from
Promega.
Statistical analysis
Data were expressed as means   SEM. All experiments were performed in
triplicates or duplicates and repeated at least three times. Statistical analy-
sis among groups was performed using t test (Origin 6.1). P-values are as
follows: */ P   0.05, **/   P   0.01, and ***/   P   0.001.
Online supplemental material
Fig. S1 indicates the role of JNK and p38 in inducing PM or DNA damage.
Low potassium-containing CGN culture exhibits high JNK and low p38 acti-
vation. p38 inhibitor SB203580 has no apparent effect on PM or DNA dam-
age. JNK inhibitor, JNKI1, provides a small but significant protection on PM368 The Journal of Cell Biology | Volume 165, Number 3, 2004
damage, through a yet unknown mechanism. Online supplemental material
is available at http://www.jcb.org/cgi/content/full/jcb.200403028/DC1.
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